These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cancer vaccines: challenges and outlook in the field. Paul S; Acres B; Limacher JM; Bonnefoy JY IDrugs; 2007 May; 10(5):324-8. PubMed ID: 17487784 [TBL] [Abstract][Full Text] [Related]
3. Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model. Berinstein NL Ann N Y Acad Sci; 2009 Sep; 1174():107-17. PubMed ID: 19769743 [TBL] [Abstract][Full Text] [Related]
4. MG7 mimotope-based DNA vaccination for gastric cancer. Zhang D; Chen Y; Fan D Expert Rev Vaccines; 2006 Apr; 5(2):223-31. PubMed ID: 16608422 [TBL] [Abstract][Full Text] [Related]
5. Cell based cancer vaccines: regulatory and commercial development. Copier J; Ward S; Dalgleish A Vaccine; 2007 Sep; 25 Suppl 2():B35-46. PubMed ID: 17916462 [TBL] [Abstract][Full Text] [Related]
6. [Immunotherapy for cancer--modern immunologic strategies in oncology]. Halama N; Zoernig I; Jäger D Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564 [TBL] [Abstract][Full Text] [Related]
8. Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy. Gridelli C; Rossi A; Maione P; Ferrara ML; Castaldo V; Sacco PC Oncologist; 2009 Sep; 14(9):909-20. PubMed ID: 19726457 [TBL] [Abstract][Full Text] [Related]
9. Current vaccine updates for lung cancer. Simmons O; Magee M; Nemunaitis J Expert Rev Vaccines; 2010 Mar; 9(3):323-35. PubMed ID: 20218860 [TBL] [Abstract][Full Text] [Related]
10. Developments in cancer vaccination. Lysaght J; Todryk S Curr Opin Investig Drugs; 2003 Jun; 4(6):716-21. PubMed ID: 12901231 [TBL] [Abstract][Full Text] [Related]
11. Vaccines for lymphomas: idiotype vaccines and beyond. Houot R; Levy R Blood Rev; 2009 May; 23(3):137-42. PubMed ID: 18951668 [TBL] [Abstract][Full Text] [Related]
12. HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunity. Yin R; Zheng W; Hao F; Yang XC; Zhong BY; Li QJ J Dermatol Sci; 2009 Aug; 55(2):116-22. PubMed ID: 19500947 [TBL] [Abstract][Full Text] [Related]
13. DNA vaccination and gene therapy: optimization and delivery for cancer therapy. Bodles-Brakhop AM; Draghia-Akli R Expert Rev Vaccines; 2008 Sep; 7(7):1085-101. PubMed ID: 18767956 [TBL] [Abstract][Full Text] [Related]
14. Current immunotherapeutic strategies in colon cancer. Morse M; Langer L; Starodub A; Hobeika A; Clay T; Lyerly HK Surg Oncol Clin N Am; 2007 Oct; 16(4):873-900, x. PubMed ID: 18022550 [TBL] [Abstract][Full Text] [Related]
15. Peptide vaccines for patients with acute myeloid leukemia. Schmitt M; Casalegno-Garduño R; Xu X; Schmitt A Expert Rev Vaccines; 2009 Oct; 8(10):1415-25. PubMed ID: 19803762 [TBL] [Abstract][Full Text] [Related]
16. Randomized clinical studies of anti-tumor vaccination: state of the art in 2008. Fournier P; Schirrmacher V Expert Rev Vaccines; 2009 Jan; 8(1):51-66. PubMed ID: 19093773 [TBL] [Abstract][Full Text] [Related]
18. Recent advances in cancer vaccines: an overview. Itoh K; Yamada A; Mine T; Noguchi M Jpn J Clin Oncol; 2009 Feb; 39(2):73-80. PubMed ID: 19015149 [TBL] [Abstract][Full Text] [Related]
19. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control. Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230 [TBL] [Abstract][Full Text] [Related]
20. Immunotherapeutics in development for prostate cancer. Harzstark AL; Small EJ Oncologist; 2009 Apr; 14(4):391-8. PubMed ID: 19342474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]